TD Asset Management
CDMO

TD Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

TD Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-127,630
Closed -$830K – 1447
2023
Q4 		$830K Buy
127,630
+12,800
+11% +$82.5K ﹤0.01% 1220
2023
Q3 		$1.08M Buy
114,830
+6,400
+6% +$77K ﹤0.01% 1121
2023
Q2 		$1.51M Buy
108,430
+200
+0.2% +$3.41K ﹤0.01% 1032
2023
Q1 		$2.03M Buy
108,230
+7,200
+7% +$118K ﹤0.01% 979
2022
Q4 		$1.39M Buy
101,030
+56,030
+125% +$858K ﹤0.01% 1080
2022
Q3 		$845K Buy
+45,000
New +$820K ﹤0.01% 1213

Other funds holding CDMO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

TD Asset Management's CDMO Position: Q1 2024 in Review

TD Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 127,630 shares — an estimated $830K sold.

TD Asset Management first reported a position in CDMO in Q3 2022 and held it in 6 quarters. The position peaked at $2.03M in Q1 2023. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • TD Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • TD Asset Management sold 127,630 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $830K.
  • TD Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • TD Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $2.03M in Q1 2023.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.